Journal of Okayama Medical Association
Published by Okayama Medical Association<Availability>
Full-text articles are available 3 years after publication.
Permalink : https://ousar.lib.okayama-u.ac.jp/67932
The 2023 Incentive Award of the Okayama Medical Association in Cancer Research (2023 Hayashibara Prize and Yamada Prize)
Obata, Taisuke
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Published Date
2024-12-02
Note
令和５年度岡山医学会賞紹介記事 (The 2023 Okayama Medical Association Awards)
受賞対象論文：Obata T, Tsutsumi K, Ueta E, Oda T, Kikuchi T, Ako S, Fujii Y, Yamazaki T, Uchida D, Matsumoto K, Horiguchi S, Kato H, Okada H, Otsuka M : MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway. Mol Ther Nucleic Acids (2023) 34, 102054.
受賞対象論文：Obata T, Tsutsumi K, Ueta E, Oda T, Kikuchi T, Ako S, Fujii Y, Yamazaki T, Uchida D, Matsumoto K, Horiguchi S, Kato H, Okada H, Otsuka M : MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway. Mol Ther Nucleic Acids (2023) 34, 102054.
DOI
ISSN
0030-1558
NCID
AN00032489